BM 567 206ROTAC PD-1/PD-L1 degrader-1 When SCD inhibition has been

When SCD inhibition has been measured by desaturation index in tissues of rodents treated with MK-8245

Palomid 529

ClH/c29-18-21-5-8-23-19-32(16-13-22(23)17-21)15-12-20-6-9-24(10-7-20)31-28(33)26-11-14-30-27-4-2-1-3-25(26)27

also known as AG-1549

WAY-204688 is an estrogen receptor (ER-α) selective

BM 567 206ROTAC PD-1/PD-L1 degrader-1 When SCD inhibition has beenIC50: 1. 1 nM for TXA2 receptor antagonism BM 567 is acting as an inhibitor of thromboxane A2 (TXA2) synthase and an antagonist of the TP receptor. Thromboxane A2 (TXA2), a potent thrombogenic and vasoconstrictor eicosanoid, is produced in large quantities by activated platelets. TXA2 has been reported as a causal factor in the onset of stroke and myocardial infarction. In vitro: BM 567 was identified as a dual acting antithrombogenic agent, acting as